| [1] |
Neame RL, Carr AJ, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte[J]. Ann Rheum Dis, 2003, 62（6）:513-518.
|
| [2] |
杨波. 肘关节镜治疗肘关节僵硬手术技巧[J/CD]. 中华肩肘外科电子杂志, 2020, 8（1）:93.
|
| [3] |
Nakamura O, Kaji Y, Yamagami Y, et al. A Rare Case of Tumoral Calcium Pyrophosphate Dihydrate Crystal Deposition Disease of the Wrist Joint[J]. Case Rep Orthop, 2015,2015:313291.
|
| [4] |
Kohn NN, Hughes RE, McCarty DJ, et al. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals[J]. Ann Intern Med, 1962, 56:738-745.
|
| [5] |
郑秋, 谢波, 张豪, 等. 关节镜治疗肘关节滑膜软骨瘤病的疗效分析[J]. 实用骨科杂志, 2020, 26（10）:917-920.
|
| [6] |
郑桂芬, 赵滨. 儿童上臂罕见骨外动脉瘤样骨囊肿1例[J]. 中国临床医学影像杂志, 2022, 33（2）:151-152.
|
| [7] |
Tedeschi SK. Issues in CPPD Nomenclature and Classification[J]. Curr Rheumatol Rep, 2019,21（9）:49.
|
| [8] |
McCarthy GM, Dunne A. Calcium crystal deposition diseases - beyond gout[J]. Nat Rev Rheumatol, 2018,14（10）:592-602.
|
| [9] |
Williams CJ, Rosenthal AK. Pathogenesis of calcium pyrophosphate deposition disease[J]. Best Pract Res Clin Rheumatol, 2021, 35（4）:101718.
|
| [10] |
Campillo-Gimenez L, Renaudin F, Jalabert M, et al. Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-kappaB Activation and MAPK Pathways[J]. Front Immunol, 2018,9:2248.
|
| [11] |
Gao M, Wang R, Yu F, et al. Evaluation of sulfane sulfur bioeffects via a mitochondria-targeting selenium-containing near-infrared fluorescent probe[J]. Biomaterials, 2018,160:1-14.
|
| [12] |
Mackenzie NC, Huesa C, Rutsch F, et al. New insights into NPP1 function: lessons from clinical and animal studies[J]. Bone, 2012,51（5）:961-968.
|
| [13] |
Onyedibe KI, Wang M, Sintim HO. ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1[J]. Molecules, 2019,24（22）:4192.
|
| [14] |
Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease[J]. N Engl J Med, 2016, 374（26）:2575-2584.
|
| [15] |
许江花, 刘冬舟. 焦磷酸钙结晶沉积症的流行病学和诊治现状[J]. 内科, 2020, 15（6）:702-706.
|
| [16] |
张孟尼, 陈铌, 龚静, 等. 小关节焦磷酸钙沉积症的临床病理分析[J]. 华西医学, 2014, 29（7）:1329-1331.
|
| [17] |
Tedeschi SK, Becce F, Pascart T, et al. Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group[J]. Arthritis Care Res （Hoboken）, 2023, 75（4）:825-834.
|
| [18] |
Finckh A, Mc CG, Madigan A, et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial[J]. Arthritis Res Ther, 2014,16（5）:458.
|
| [19] |
Stack J, McCarthy G. Calcium pyrophosphate deposition （CPPD） disease - Treatment options[J]. Best Pract Res Clin Rheumatol, 2021,35（4）:101720.
|
| [20] |
胥少汀, 葛宝丰, 卢世壁. 实用骨科学（第4版修订本 下册）[M]. 4版. 郑州: 河南科学技术出版社, 2019:1834-1836.
|
| [21] |
姜艳, 邢小平, 李梅, 等. 阿法骨化醇治疗骨质疏松症有效性和安全性的Meta分析[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14（3）:221-229.
|
| [22] |
Couture G, Delzor F, Bagheri H, et al. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy[J]. Joint Bone Spine, 2017, 84（2）:213-215.
|
| [23] |
张一翀, 王艳华, 张殿英. 肘管综合征的研究进展[J/CD]. 中华肩肘外科电子杂志, 2017, 5（3）:221-225.
|
| [24] |
Cowley S, McCarthy G. Diagnosis and Treatment of Calcium Pyrophosphate Deposition （CPPD） Disease: A Review[J]. Open Access Rheumatol, 2023,15:33-41.
|